Tue, May 22, 2012
Scientists turn skin cells into beating heart muscle
By Kate Kelland
LONDON (Reuters) - Scientists have for the first time succeeded in taking skin cells from patients with heart failure and transforming them ...
Tue, May 22, 2012
Death rate drops among Americans with diabetes -CDC
By David Beasley
ATLANTA (Reuters) - A 40 percent decline in the death rate of diabetic American adults from heart disease and strokes is a ...
Tue, May 22, 2012
U.S. says drug abuse needs treatment, not just jail
By Kate Kelland
LONDON (Reuters) - The United States sees drug abuse as a public health problem as much as a crime issue and is ...
Tue, May 22, 2012
Internet domain name project relaunches after software bug
By Georgina Prodhan
LONDON (Reuters) - A project to allow companies to set up a website with almost any address has relaunched after a software ...
Tue, May 22, 2012
Folic acid tied to lower child cancer risks
By Amy Norton
NEW YORK (Reuters Health) - Rates of two rare childhood cancers declined after the U.S. began requiring grain products to be ...
Tue, May 22, 2012
Many babies with development delays may go untreated
By Kerry Grens
NEW YORK (Reuters Health) - About one out of every three infants who scores well below average on a test of developmental ...
Tue, May 22, 2012
Mom's excess pounds key in newborn weight
By Amy Norton
NEW YORK (Reuters Health) - For at least some moms-to-be, it's extra body fat -- and not blood sugar levels -- that may ...
Tue, May 22, 2012
Exercise tied to lower risk of psoriasis: study
By Genevra Pittman
NEW YORK (Reuters Health) - Results from a large U.S. study suggest women who regularly exercise vigorously, including runners and aerobics ...
Tue, May 22, 2012
Takeda drug impresses in ulcerative colitis study
By Bill Berkrot
(Reuters) - More than 40 percent of patients with moderate to severe ulcerative colitis achieved clinical remission from the debilitating condition after ...
Tue, May 22, 2012
Eli Lilly's diabetes drug meets mid-stage trial goal
(Reuters) - Drugmaker Eli Lilly and Co's experimental drug to treat type 2 diabetes met the main goal of a mid-stage trial to test ...
Recent Comments